Mutation screening of RAD51C in male breast cancer patients.
作者信息
Silvestri Valentina, Rizzolo Piera, Falchetti Mario, Zanna Ines, Masala Giovanna, Palli Domenico, Ottini Laura
出版信息
Breast Cancer Res. 2011 Feb 8;13(1):404. doi: 10.1186/bcr2823.
Abstract
摘要
相似文献
1
Mutation screening of RAD51C in male breast cancer patients.男性乳腺癌患者中RAD51C的突变筛查
Breast Cancer Res. 2011 Feb 8;13(1):404. doi: 10.1186/bcr2823.
2
Pathological features of breast and ovarian cancers in RAD51C germline mutation carriers.RAD51C种系突变携带者的乳腺癌和卵巢癌的病理特征。
Virchows Arch. 2014 Sep;465(3):365-9. doi: 10.1007/s00428-014-1619-1. Epub 2014 Jul 4.
3
RAD51C germline mutations in breast and ovarian cancer patients.乳腺癌和卵巢癌患者中的RAD51C种系突变
Breast Cancer Res. 2010;12(4):404. doi: 10.1186/bcr2619. Epub 2010 Aug 19.
4
A HRM-based screening method detects RAD51C germ-line deleterious mutations in Spanish breast and ovarian cancer families.基于 HRM 的筛选方法在西班牙乳腺癌和卵巢癌家族中检测 RAD51C 胚系有害突变。
Breast Cancer Res Treat. 2011 Oct;129(3):939-46. doi: 10.1007/s10549-011-1543-x. Epub 2011 May 3.
5
RAD51C germline mutations found in Spanish site-specific breast cancer and breast-ovarian cancer families.在西班牙特定部位乳腺癌和乳腺-卵巢癌家族中发现的RAD51C种系突变。
Breast Cancer Res Treat. 2014 Aug;147(1):133-43. doi: 10.1007/s10549-014-3078-4. Epub 2014 Aug 3.
6
Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility.进一步证明 RAD51C 基因在遗传性乳腺癌和卵巢癌易感性中的作用。
Breast Cancer Res Treat. 2011 Dec;130(3):1003-10. doi: 10.1007/s10549-011-1677-x. Epub 2011 Jul 13.
7
Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients.分析高危乳腺癌和卵巢癌家族及卵巢癌患者的 RAD51C 种系突变。
Hum Mutat. 2012 Jan;33(1):95-9. doi: 10.1002/humu.21625. Epub 2011 Nov 4.
8
Identification of six pathogenic RAD51C mutations via mutational screening of 1228 Danish individuals with increased risk of hereditary breast and/or ovarian cancer.通过对1228名遗传性乳腺癌和/或卵巢癌风险增加的丹麦个体进行突变筛查，鉴定出六种致病性RAD51C突变。
Breast Cancer Res Treat. 2016 Jan;155(2):215-22. doi: 10.1007/s10549-015-3674-y. Epub 2016 Jan 6.
9
Combined Tumor Sequencing and Case-Control Analyses of RAD51C in Breast Cancer.乳腺癌中 RAD51C 的联合肿瘤测序和病例对照分析。
J Natl Cancer Inst. 2019 Dec 1;111(12):1332-1338. doi: 10.1093/jnci/djz045.
10
Germline RAD51C mutations in ovarian cancer susceptibility.胚系 RAD51C 突变与卵巢癌易感性
Clin Genet. 2013 Apr;83(4):332-6. doi: 10.1111/j.1399-0004.2012.01917.x. Epub 2012 Jul 23.
引用本文的文献
1
Gender-Specific Genetic Predisposition to Breast Cancer: Genes and Beyond.乳腺癌的性别特异性遗传易感性：基因及其他因素
Cancers (Basel). 2024 Jan 30;16(3):579. doi: 10.3390/cancers16030579.
2
A comprehensive study on surveillance outcomes of a male population followed at a hereditary breast cancer high-risk consultation at a Portuguese tertiary hospital.葡萄牙一家三级医院遗传性乳腺癌高危咨询门诊随访的男性人群监测结果的综合研究。
J Cancer Res Clin Oncol. 2023 Oct;149(13):11145-11156. doi: 10.1007/s00432-023-04994-7. Epub 2023 Jun 22.
3
Male Breast Cancer: Results of the Application of Multigene Panel Testing to an Italian Cohort of Patients.男性乳腺癌：多基因检测在意大利患者队列中的应用结果
Diagnostics (Basel). 2020 Apr 30;10(5):269. doi: 10.3390/diagnostics10050269.
4
CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population.CHEK2 c.1100delC 突变与芬兰患者群体中男性乳腺癌风险增加相关。
BMC Cancer. 2017 Sep 5;17(1):620. doi: 10.1186/s12885-017-3631-8.
5
Collaboration of colorado cancer genetic counselors to integrate next generation sequencing panels into clinical practice.科罗拉多州癌症遗传咨询师合作将新一代测序面板整合到临床实践中。
J Genet Couns. 2014 Aug;23(4):640-6. doi: 10.1007/s10897-014-9718-3. Epub 2014 May 1.
6
Inherited and acquired alterations in development of breast cancer.乳腺癌发生过程中的遗传和后天改变。
Appl Clin Genet. 2011 Nov 14;4:145-58. doi: 10.2147/TACG.S13226. Print 2011.
7
Germline RAD51C mutations confer susceptibility to ovarian cancer.种系RAD51C突变会增加患卵巢癌的易感性。
Nat Genet. 2012 Apr 26;44(5):475-6; author reply 476. doi: 10.1038/ng.2224.
8
Mutation screening of RAD51C in high-risk breast and ovarian cancer families.RAD51C 基因突变筛查在高危乳腺癌和卵巢癌家族中的应用。
Fam Cancer. 2012 Sep;11(3):381-5. doi: 10.1007/s10689-012-9523-9.
本文引用的文献
1
Mutation analysis of BRIP1 in male breast cancer cases: a population-based study in Central Italy.BRIP1 基因突变分析在男性乳腺癌病例中的应用：意大利中部的一项基于人群的研究。
Breast Cancer Res Treat. 2011 Apr;126(2):539-43. doi: 10.1007/s10549-010-1289-x. Epub 2010 Dec 17.
2
RAD51C germline mutations in breast and ovarian cancer patients.乳腺癌和卵巢癌患者中的RAD51C种系突变
Breast Cancer Res. 2010;12(4):404. doi: 10.1186/bcr2619. Epub 2010 Aug 19.
3
Screening RAD51C nucleotide alterations in patients with a family history of breast and ovarian cancer.对有乳腺癌和卵巢癌家族史的患者进行 RAD51C 核苷酸改变的筛查。
Breast Cancer Res Treat. 2010 Dec;124(3):857-61. doi: 10.1007/s10549-010-1095-5. Epub 2010 Aug 10.
4
Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene.家族性乳腺癌和卵巢癌中的胚系突变将 RAD51C 确立为人类癌症易感性基因。
Nat Genet. 2010 May;42(5):410-4. doi: 10.1038/ng.569. Epub 2010 Apr 18.
5
BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central Italy.托斯卡纳108例男性乳腺癌病例的BRCA1/BRCA2突变状态及临床病理特征：意大利中部一项基于人群的研究
Breast Cancer Res Treat. 2009 Aug;116(3):577-86. doi: 10.1007/s10549-008-0194-z. Epub 2008 Sep 26.
Zotero 插件